v3.25.2
Income Taxes (Tables)
 12 Months Ended
Mar. 31, 2025
Income taxes paid (refund) [abstract]  
Schedule of Composition of Income Tax Expense (Benefit)
The composition of income tax expense (benefit) is as follows:
JPY (millions)
For the Year Ended March 31
202320242025
Current tax expense
¥246,578 ¥107,349 ¥138,057 
Deferred tax benefit
(188,526)(198,755)(71,116)
Total
¥58,052 ¥(91,406)¥66,941 
Schedule of Reconciliation from Income Tax Expense (Benefit)
The following is a reconciliation from income tax expense at Takeda's domestic (Japanese) statutory tax rate to Takeda's income tax expense (benefit) reported for the year ended March 31:
JPY (millions)
202320242025
Profit before tax
¥375,090 ¥52,791 ¥175,084 
Income tax expense at Takeda’s domestic (Japanese) statutory tax rate of 30.6%
114,703 16,143 53,541 
Non-deductible expenses for tax purposes (1)
15,158 21,353 25,860 
Changes in unrecognized deferred tax assets and deferred tax liabilities (2)
(21,791)(3,512)45,243 
Tax credits
(26,676)(30,654)(28,371)
Differences in applicable tax rates of overseas subsidiaries (3)
(31,446)(29,782)(39,963)
Changes in tax effects of undistributed profit of overseas subsidiaries
6,174 (1,737)10,282 
Effect of changes in applicable tax rates and tax law (4)
2,482 (11,994)(6,964)
Tax contingencies (5)
13,991 (83,784)426 
Effect of prior year items
(7,524)(2,479)3,305 
Entity reorganizations/Divestments
(6,321)33,469 2,880 
Other
(698)1,571 702 
Income tax expense (benefit) reported for the year
¥58,052 ¥(91,406)¥66,941 
(1) Amounts for the years ended March 31, 2023, 2024 and 2025 include the impact from intra territory eliminations, the pre-tax effect of which has been eliminated in arriving at Takeda’s consolidated income from continuing operations before income taxes. Additionally, amounts for the years ended March 31, 2023, 2024 and 2025 include non-deductible interest due to Japanese earnings stripping rules.
(2) Amounts for the years ended March 31, 2023, 2024 and 2025 include deferred tax expenses (benefits) associated with carried forward net operating losses. The amount for the year ended March 31, 2023 is driven by recognition of tax benefits from previously unrecognized tax losses as result of internal entity restructuring transactions. Amounts for the year ended March 31, 2025 includes JPY 21,600 million of deferred tax expense related to derecognition of previously recognized interest expense carryforwards under Japanese earnings stripping rules.
(3) Amounts for the years ended March 31, 2023, and 2024 include unitary and minimum taxes on overseas subsidiaries. Amount for the year ended 2025 includes unitary, minimum and Pillar Two taxes on overseas subsidiaries.
(4) Amounts for the year ended March 31, 2024 includes JPY 4,206 million deferred tax expense related to US state law change and JPY 16,200 million deferred tax benefit relating to extension of the carryforward period relating to Japanese earnings stripping rules. Amounts for the year ended March 31, 2025 includes JPY 5,809 million deferred tax benefit related to US state law changes and JPY 1,155 million deferred tax benefit related to the change in Japan's enacted tax rate (from 30.6% to 31.5%) for years beginning April 1, 2026.
(5) Tax benefit for the year ended March 31, 2024 is from favorable resolutions of tax contingencies including JPY 63,547 million relating to the settlement with Irish Revenue Commissioners with respect to a tax assessment related to the treatment of an acquisition break fee Shire received from AbbVie in 2014.
Schedule of Deferred Taxes
Deferred tax assets and liabilities reported in the consolidated statements of financial position are as follows:
JPY (millions)
As of March 31
20242025
Deferred tax assets
¥393,865 ¥370,745 
Deferred tax liabilities
(113,777)(35,153)
Net deferred tax assets
¥280,088 ¥335,592 
The major items and changes in deferred tax assets and liabilities are as follows:
JPY (millions)
As of April 1, 2023Recognized in profit or (loss)Recognized in other comprehensive income
Other(1)
As of March 31, 2024
Research and development expenses¥136,230 ¥77,180 ¥— ¥3,600 ¥217,010 
Inventories110,911 20,482 — 7,009 138,402 
Property, plant and equipment(71,759)9,249 — (5,999)(68,509)
Intangible assets(452,594)99,039 — (36,715)(390,270)
Financial assets measured at FVTOCI(5,128)— (2,056)(455)(7,639)
Accrued expenses and provisions165,043 7,469 — 13,081 185,593 
Defined benefit plans6,406 667 2,170 5,485 14,728 
Deferred income7,432 (1,955)— 16 5,493 
Unused tax losses101,092 (15,970)— 3,549 88,671 
Tax credits52,091 (11,230)— 5,298 46,159 
Investments in subsidiaries and associates(36,838)10,183 — (146)(26,801)
Cash flow hedges38,480 2,227 (19,062)— 21,645 
Other44,017 1,414 (3,171)13,346 55,606 
Total¥95,383 ¥198,755 ¥(22,119)¥8,069 ¥280,088 
JPY (millions)
As of April 1, 2024Recognized in profit or (loss)Recognized in other comprehensive income
Other(1)
As of March 31, 2025
Research and development expenses¥217,010 ¥53,732 ¥— ¥9,816 ¥280,558 
Inventories138,402 64,265 — (10,788)191,879 
Property, plant and equipment(68,509)5,332 — (1,839)(65,016)
Intangible assets(390,270)65,032 — (16,599)(341,837)
Financial assets measured at FVTOCI(7,639)— 4,235 1,119 (2,285)
Accrued expenses and provisions185,593 (75,010)— 7,624 118,207 
Defined benefit plans14,728 (3,768)2,231 375 13,566 
Deferred income5,493 (875)— 41 4,659 
Unused tax losses88,671 (36,355)— 2,973 55,289 
Tax credits46,159 (21,469)— 2,664 27,354 
Investments in subsidiaries and associates(26,801)17,595 — (361)(9,567)
Cash flow hedges21,645 2,969 3,775 1,461 29,850 
Other55,606 (332)(3,350)(18,989)32,935 
Total¥280,088 ¥71,116 ¥6,891 ¥(22,503)¥335,592 
(1) Other consists primarily of foreign currency translation differences, reclassification of deferred tax assets and liabilities classified as held for sale and the tax impact of items charged directly to equity.
The unused tax losses, deductible temporary differences, and unused tax credits for which deferred tax assets were not recognized are as follows:
JPY (millions)
As of March 31
20242025
Unused tax losses¥1,186,106 ¥1,183,701 
Deductible temporary differences263,143 427,373 
Unused tax credits23,724 26,993 
The unused tax losses and unused tax credits for which deferred tax assets were not recognized will expire as follows:
JPY (millions)
As of March 31
Unused tax losses20242025
1st year¥812 ¥114 
2nd year85 1,278 
3rd year1,989 2,375 
4th year6,233 549,705 
5th year578,648 469,391 
After 5th year590,813 152,121 
Indefinite7,526 8,717 
Total¥1,186,106 ¥1,183,701 
JPY (millions)
As of March 31
Unused tax credits20242025
Less than 5 years¥3,901 ¥3,715 
5 years or more19,823 23,278 
Indefinite— — 
Total¥23,724 ¥26,993